A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma
出版年份 2022 全文链接
标题
A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma
作者
关键词
-
出版物
Nature Communications
Volume 13, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-07-22
DOI
10.1038/s41467-022-31262-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas
- (2021) Gregory K. Friedman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncolytic herpes virus G47Δ works synergistically with CTLA-4 inhibition through dynamic intratumoral immune modulation
- (2021) Kotaro Sugawara et al. Molecular Therapy-Oncolytics
- Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial
- (2021) Jawad Fares et al. LANCET ONCOLOGY
- Oncolytic herpes virus G47Δ injected into tongue cancer swiftly traffics in lymphatics and suppresses metastasis
- (2021) Toshihiro Uchihashi et al. Molecular Therapy-Oncolytics
- Efficacy and safety of a third-generation oncolytic herpes virus G47Δ in models of human esophageal carcinoma
- (2021) Shoh Yajima et al. Molecular Therapy-Oncolytics
- Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
- (2020) Dipongkor Saha et al. Journal for ImmunoTherapy of Cancer
- Efficacy of a Third-Generation Oncolytic Herpes Virus G47Δ in Advanced Stage Models of Human Gastric Cancer
- (2020) Kotaro Sugawara et al. Molecular Therapy-Oncolytics
- Neoadjuvant Use of Oncolytic Herpes Virus G47Δ Enhances the Antitumor Efficacy of Radiofrequency Ablation
- (2020) Tomoharu Yamada et al. Molecular Therapy-Oncolytics
- Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models
- (2018) Dipongkor Saha et al. CLINICAL CANCER RESEARCH
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current status of clinical trials assessing oncolytic virus therapy for urological cancers
- (2017) Satoru Taguchi et al. INTERNATIONAL JOURNAL OF UROLOGY
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Oncolytic virus therapy: A new era of cancer treatment at dawn
- (2016) Hiroshi Fukuhara et al. CANCER SCIENCE
- Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma
- (2016) Jacob J. Mandel et al. JOURNAL OF NEURO-ONCOLOGY
- Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy
- (2016) Hasan Rehman et al. Journal for ImmunoTherapy of Cancer
- A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses
- (2014) James M Markert et al. MOLECULAR THERAPY
- Expression of FMS-like Tyrosine Kinase 3 Ligand by Oncolytic Herpes Simplex Virus Type I Prolongs Survival in Mice Bearing Established Syngeneic Intracranial Malignant Glioma
- (2012) Zachary Barnard et al. NEUROSURGERY
- Oncolytic Herpes Simplex Virus Counteracts the Hypoxia-Induced Modulation of Glioblastoma Stem-Like Cells
- (2012) Donatella Sgubin et al. Stem Cells Translational Medicine
- Enhanced Antitumor Efficacy of Low-Dose Etoposide with Oncolytic Herpes Simplex Virus in Human Glioblastoma Stem Cell Xenografts
- (2011) T. A. Cheema et al. CLINICAL CANCER RESEARCH
- Oncolytic Virus-Mediated Manipulation of DNA Damage Responses: Synergy With Chemotherapy in Killing Glioblastoma Stem Cells
- (2011) Ryuichi Kanai et al. JNCI-Journal of the National Cancer Institute
- Bevacizumab With Angiostatin-armed oHSV Increases Antiangiogenesis and Decreases Bevacizumab-induced Invasion in U87 Glioma
- (2011) Wei Zhang et al. MOLECULAR THERAPY
- Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells
- (2009) B J Passer et al. CANCER GENE THERAPY
- Human Glioblastoma-Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
- (2009) H. Wakimoto et al. CANCER RESEARCH
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Analysis of genetically engineered oncolytic herpes simplex viruses in human prostate cancer organotypic cultures
- (2009) B J Passer et al. GENE THERAPY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Combination Immunotherapy for Tumors via Sequential Intratumoral Injections of Oncolytic Herpes Simplex Virus 1 and Immature Dendritic Cells
- (2008) C. J. Farrell et al. CLINICAL CANCER RESEARCH
- Trichostatin A and Oncolytic HSV Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects
- (2008) Ta-Chiang Liu et al. MOLECULAR THERAPY
- Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM
- (2008) James M Markert et al. MOLECULAR THERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started